KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares Issued
Ratios

Jazz Pharmaceuticals (JAZZ) Shares Repurchased: 2013-2024

Historic Shares Repurchased for Jazz Pharmaceuticals (JAZZ) over the last 6 years, with Sep 2024 value amounting to $150.0 million.

  • Jazz Pharmaceuticals' Shares Repurchased rose 101.69% to $150.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $331.7 million, marking a year-over-year increase of 0.12%. This contributed to the annual value of $311.4 million for FY2024, which is 15.45% up from last year.
  • Jazz Pharmaceuticals' Shares Repurchased amounted to $150.0 million in Q3 2024, which was up 50.31% from $99.8 million recorded in Q4 2023.
  • Jazz Pharmaceuticals' Shares Repurchased's 5-year high stood at $150.0 million during Q3 2024, with a 5-year trough of $7.5 million in Q2 2020.
  • Over the past 2 years, Jazz Pharmaceuticals' median Shares Repurchased value was $99.8 million (recorded in 2023), while the average stood at $108.1 million.
  • As far as peak fluctuations go, Jazz Pharmaceuticals' Shares Repurchased tumbled by 87.50% in 2020, and later spiked by 101.69% in 2024.
  • Over the past 3 years, Jazz Pharmaceuticals' Shares Repurchased (Quarterly) stood at $7.5 million in 2020, then reached $99.8 million in 2023, then spiked by 101.69% to $150.0 million in 2024.
  • Its Shares Repurchased stands at $150.0 million for Q3 2024, versus $99.8 million for Q4 2023 and $74.4 million for Q3 2023.